The number of mitochondrial DNA copies may drop as MS progresses, suggesting a possible biomarker for disease progression, a ...

Quantum Biopharma plans to file an application by year's end seeking FDA clearance for a Phase 2 clinical trial testing Lucid ...

Copaxone and generic versions of glatiramer acetate are injected under the skin at 20 mg/mL daily or 40 mg/mL three times a ...

It may be largely invisible to others, but the cognitive fog associated with MS can be difficult to manage, says columnist.

Higher levels of a type of bacteria called Lachnospiraceae in the gut may be a key risk factor for multiple sclerosis (MS), ...

Worsening disability may increase the risk of bone mineral density loss in MS, potentially leading to fractures, a study ...

Levels of B-cells can help to predict the risk of disability progression independent of relapse activity in relapsing MS ...